CATEG 30 CAPSULES OF 200 mg

Notice is hereby given that, as a result of a partial demerger, effective February 1, 2023, the business unit of Sofar S.p.A. was transferred to Alfasigma S.p.A., which, as of that date, took over for all legal purposes and without interruption all the relationships previously belonging to Sofar S.p.A., including the ownership of the relevant websites and domain names.

In accordance with applicable data protection laws, and in particular in compliance with the Garante per la Protezione dei Dati Personali’s order of April 8, 2009 “Prescrizioni in materia di operazioni di fusione e scissione fra società” (published in the Official Gazette No. 106 of May 9, 2009), Alfasigma S.p.A. will take over as controller of the personal data related to the above-mentioned data already processed by Sofar S.p.A.